How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) released its earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider earned $19.69 million during the quarter. Misonix had a negative net margin of 19.55% and a negative trailing twelve-month return on equity of 10.36%.

What is Michael A. McManus Jr.'s approval rating as Misonix's CEO?

3 employees have rated Misonix Chief Executive Officer Michael A. McManus Jr. on Glassdoor.com . Michael A. McManus Jr. has an approval rating of 33% among the company's employees. This puts Michael A. McManus Jr. in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Misonix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Misonix investors own include Edap Tms (EDAP) , Varian Medical Systems (VAR) , Sociedad Química y Minera de Chile (SQM) , Avadel Pharmaceuticals (AVDL) , Second Sight Medical Products (EYES) , Aldeyra Therapeutics (ALDX) , Ardelyx (ARDX) and Athenex (ATNX) .

NASDAQ:MSON

Misonix (MSON) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)

Free MSON Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $26.54
▼
$26.54
50-Day Range: $24.89
▼
$26.54
52-Week Range: $11.04
▼
$26.99

Volume: 2 shs
Average Volume: 60,302 shs
Market Capitalization: $462.06 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Misonix alerts:

Ad WealthPress

The system that called 2023’s top 7 stocks is at it again…

Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.

Just follow this link here!

About Misonix Stock (NASDAQ:MSON)

Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.

Ad WealthPress

The system that called 2023’s top 7 stocks is at it again…

Just follow this link here!

MSON Stock News Headlines

April 17, 2024 | msn.com

Somerset Freemason to run 65th marathon for cause close to his heart

April 13, 2024 | msn.com

Mason’s Tex Smith signs to attend U.S. Military Academy at West Point

April 19, 2024 | Banyan Hill Publishing (Ad)

The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

April 12, 2024 | msn.com

Your Very Own Masonic Temple in Hillsdale

April 11, 2024 | msn.com

In Mason, Indian food takes on a whole new color at My Kolorful Kitchen

April 10, 2024 | msn.com

Minot Masons seeking organizations for July 4th Parade

April 10, 2024 | msn.com

Mason’s mysterious death: Two brothers-in-law arrested in Odisha

April 9, 2024 | msn.com

Coronation Street fans left with question as they declare 'for once' after Mason verdict

April 19, 2024 | Banyan Hill Publishing (Ad)

The Best AI Stock to Own in the World Today is Trading for Just $25

April 8, 2024 | sports.yahoo.com

Moeller and Mason's future bout, Beechwood's bats highlight baseball storylines

April 4, 2024 | msn.com

Mason’s Inlet dredging and beach renourishment completed

April 4, 2024 | msn.com

Palghar: Mason Arrested 29 Years After Killing His Peer

March 31, 2024 | msn.com

Texas Court Reverses Crystal Mason's Conviction, Questions Evidence of 'Knowingly' Illegal Voting

March 29, 2024 | msn.com

Maddow Blog | Crystal Mason's five-year prison sentence is overturned in Texas

March 29, 2024 | msn.com

Texas appeals court overturns Crystal Mason's conviction, 5-year sentence for illegal voting

March 29, 2024 | msn.com

Crystal Mason’s voter fraud conviction overturned

March 28, 2024 | msn.com

How the Texans created $6.4 million in Shaq Mason's restructured contract

March 28, 2024 | msn.com

Mason's Matula, Purcell Marian's Mosley named OHSBCA Coaches of the Year

March 28, 2024 | uk.news.yahoo.com

Pinsent Masons blazes a trail as finance goes digital

March 27, 2024 | msn.com

Payne Education Center receives $225,000 grant for teacher training in literacy programs

March 26, 2024 | uk.news.yahoo.com

Local masons from oldest Inverclyde institution hold Burns Club supper

March 25, 2024 | msn.com

City of Jackson bringing new life to former Masonic Temple after more than a decade of vacancy

March 23, 2024 | yahoo.com

Goshen landmark now under new management

March 19, 2024 | msn.com

New steakhouse by well-known South Shore restaurateur to open in Quincy this fall

March 11, 2024 | msn.com

Three teens charged after transgender girl stabbed at roller-skating party

March 6, 2024 | msn.com

Meet The Easter Bunny To Be Hosted At The Mason Lodge

March 6, 2024 | msn.com

ITV Coronation Street fans rumble Mason's DNA link to Weatherfield after spotting clue

See More Headlines

Receive MSON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/02/2021
Today: 4/19/2024
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Computer and Technology
Industry: Laboratory Apparatus & Furniture
Sub-Industry: N/A
Current Symbol: NASDAQ:MSON
CUSIP: N/A
CIK: 880432
Web: www.misonix.com
Phone: (631) 694-9555
Fax: 631-694-9412
Employees: 254
Year Founded: 1959

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-14,470,000.00
Net Margins: -19.55%
Pretax Margin: -19.37%
Return on Equity: -10.36%
Return on Assets: -7.29%

Debt

Debt-to-Equity Ratio: 0.29
Current Ratio: 2.61
Quick Ratio: 1.92

Sales & Book Value

Annual Sales: $74.02 million
Price / Sales: 6.24
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $7.77 per share
Price / Book: 3.42

Miscellaneous

Outstanding Shares: 17,410,000
Free Float: 11,893,000
Market Cap: $462.06 million
Optionable: Not Optionable
Beta: 1.36

Social Links

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Stavros G. Vizirgianakis
Chief Executive Officer & Director
Allan R. Staley
President
Sharon W. Klugewicz
Chief Operating Officer
Joseph P. Dwyer
Chief Financial Officer, Secretary & Treasurer
Daniel Voic
VP-Engineering, Research & Development

Key Competitors

View All Competitors

MSON Stock Analysis - Frequently Asked Questions

How were Misonix's earnings last quarter?: Misonix, Inc. (NASDAQ:MSON) released its earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider earned $19.69 million during the quarter. Misonix had a negative net margin of 19.55% and a negative trailing twelve-month return on equity of 10.36%.
What is Michael A. McManus Jr.'s approval rating as Misonix's CEO?: 3 employees have rated Misonix Chief Executive Officer Michael A. McManus Jr. on Glassdoor.com. Michael A. McManus Jr. has an approval rating of 33% among the company's employees. This puts Michael A. McManus Jr. in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Misonix own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Misonix investors own include Edap Tms (EDAP), Varian Medical Systems (VAR), Sociedad Química y Minera de Chile (SQM), Avadel Pharmaceuticals (AVDL), Second Sight Medical Products (EYES), Aldeyra Therapeutics (ALDX), Ardelyx (ARDX) and Athenex (ATNX).

This page (NASDAQ:MSON) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Misonix (MSON) Stock Price, News & Analysis

About Misonix Stock (NASDAQ:MSON)

MSON Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

MSON Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info